BPC-157 Molecular Specifications The following technical data defines the chemical profile of BPC-157 (Body Protection Compound 157) available through our wholesale catalog
Studies showed a remarkable effect on people with obesity: The SELECT Trial found that MACE (major adverse CVD event) risk was reduced by 20% in adults with obesity without T2D in the group taking semaglutide
Most patients notice early weight loss results within 4-6 weeks, while longer-term progress builds over the following months
If eligible, a Ro-affiliated provider will write you an Rx for GLP-1 medication, be it Wegovy, Zepbound, Foundayo, or Ozempic
If you collect your order in the Netherlands:* You must go to customs when leaving the EU and present the required documents and medicines
Discontinue use and consult a medical doctor if you experience any unusual symptoms